Modifications of proteins by polyunsaturated fatty acid peroxidation products.
The ability of unsaturated fatty acid methyl esters to modify amino acid residues in bovine serum albumin (BSA), glutamine synthetase, and insulin in the presence of a metal-catalyzed oxidation system [ascorbate/Fe(III)/O(2)] depends on the degree of unsaturation of the fatty acid. The fatty acid-dependent generation of carbonyl groups and loss of lysine residues increased in the order methyl linoleate < methyl linolenate < methyl arachidonate. The amounts of alkyl hydroperoxides, malondialdehyde, and a number of other aldehydes that accumulated when polyunsaturated fatty acids were oxidized in the presence of BSA were significantly lower than that observed in the absence of BSA. Direct treatment of proteins with various lipid hydroperoxides led to a slight increase in the formation of protein carbonyl derivatives, whereas treatment with the hydroperoxides together with Fe(II) led to a substantial increase in the formation of protein carbonyls. These results are consistent with the proposition that metal-catalyzed oxidation of polyunsaturated fatty acids can contribute to the generation of protein carbonyls by direct interaction of lipid oxidation products (alpha,beta-unsaturated aldehydes) with lysine residues (Michael addition reactions) and also by interactions with alkoxyl radicals obtained by Fe(II) cleavage of lipid hydroperoxides that are formed. In addition, saturated aldehydes derived from the polyunsaturated fatty acids likely react with lysine residues to form Schiff base adducts.
Refsgaard
H H
HH
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-0342, USA.
Tsai
L
L
Stadtman
E R
ER
D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D002255:Carbonic Acid / Q000378:metabolism; D002417:Cattle; D005231:Fatty Acids, Unsaturated / Q000378:metabolism* / Q000494:pharmacology; D005974:Glutamate-Ammonia Ligase / Q000187:drug effects / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D008041:Linoleic Acids / Q000494:pharmacology; D008042:Linolenic Acids / Q000494:pharmacology; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000378:metabolism / Q000494:pharmacology*; D008239:Lysine / Q000187:drug effects / Q000378:metabolism; D008315:Malondialdehyde / Q000378:metabolism; D010084:Oxidation-Reduction; D011506:Proteins / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism
D005231:Fatty Acids, Unsaturated; D007328:Insulin; D008041:Linoleic Acids; D008042:Linolenic Acids; D008054:Lipid Peroxides; D011506:Proteins; C047376:methyl linolenate; C005575:methyl linoleate; D012710:Serum Albumin, Bovine; D016718:Arachidonic Acid; D002255:Carbonic Acid; D008315:Malondialdehyde; D005974:Glutamate-Ammonia Ligase; D008239:Lysine